Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text |  PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_39_2023 |
1,390 | 85,896 | 87,286 |
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_31_2023 |
3,230 | 83,615 | 86,845 |
CommentaryStatus of research and publication in IndiaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_29_2023 |
2,412 | 73,624 | 76,036 |
EditorialEczema and skin allergy-focus on researchFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_29_2024 |
1,442 | 60,541 | 61,983 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_52_2023 |
3,110 | 44,293 | 47,403 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_45_2023 |
2,976 | 40,298 | 43,274 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_15_2024 |
2,073 | 38,983 | 41,056 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2023 |
2,415 | 37,258 | 39,673 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_14_2024 |
1,430 | 35,418 | 36,848 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_26_2023 |
3,462 | 24,682 | 28,144 |
SymposiumInvestigations and treatment of photodermatosesFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_6_2024 |
2,074 | 21,078 | 23,152 |
Case ReportA novel pitch against the itchFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_13_2024 |
2,798 | 18,991 | 21,789 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_3_2024 |
2,511 | 18,897 | 21,408 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_44_2023 |
5,223 | 14,372 | 19,595 |
ImageGiant fixed drug eruptionFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_47_2023 |
2,325 | 14,046 | 16,371 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_19_2024 |
1,896 | 13,702 | 15,598 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_9_2024 |
2,953 | 11,067 | 14,020 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_3_2021 |
11,185 | 2,547 | 13,732 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_1_2024 |
1,741 | 11,479 | 13,220 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_42_2023 |
1,583 | 11,498 | 13,081 |
SymposiumCutaneous photobiologyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_11_2024 |
2,492 | 9,210 | 11,702 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_48_2023 |
2,556 | 9,008 | 11,564 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_5_2021 |
8,912 | 2,359 | 11,271 |
Review ArticleA review of comorbidities in atopic dermatitisFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2024 |
3,411 | 7,573 | 10,984 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_28_2023 |
2,309 | 8,561 | 10,870 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_4_2024 |
1,942 | 8,785 | 10,727 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_51_2023 |
2,585 | 7,751 | 10,336 |
SymposiumPolymorphous light eruptionsFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_8_2024 |
1,968 | 8,332 | 10,300 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_5_2024 |
2,763 | 7,410 | 10,173 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_31_2024 |
1,366 | 8,803 | 10,169 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_50_2023 |
3,902 | 6,091 | 9,993 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_25_2023 |
1,693 | 8,231 | 9,924 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_16_2024 |
3,846 | 6,041 | 9,887 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_30_2023 |
1,896 | 7,502 | 9,398 |
SymposiumChronic actinic dermatitisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_10_2024 |
2,152 | 6,931 | 9,083 |
Original ArticleAtopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospitalFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_21_2022 |
1,698 | 7,320 | 9,018 |
Review ArticleJAK inhibitors in dermatologyFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_7_2021 |
6,577 | 2,434 | 9,011 |
Letter to EditorTeledermatology trends during two waves of the COVID-19 pandemic – Experience from western RajasthanFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_21_2024 |
1,422 | 7,238 | 8,660 |
Author’s replyPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_41_2024 |
1,395 | 7,086 | 8,481 |
Letter to EditorAre dermatologists a well-informed audience for artificial intelligence? A knowledge, attitude, and practice surveyFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_20_2024 |
1,696 | 4,957 | 6,653 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_22_2022 |
3,452 | 2,609 | 6,061 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_11_2021 |
3,562 | 2,161 | 5,723 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_14_2023 |
3,836 | 1,777 | 5,613 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_12_2021 |
3,700 | 1,659 | 5,359 |
Review ArticleDigital object identifier: What it is and why it matters?Full text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_20_2023 |
3,598 | 1,315 | 4,913 |
Letter to EditorVitamin D levels in patients with chronic spontaneous urticariaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_3_2023 |
2,929 | 1,880 | 4,809 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_41_2023 |
1,759 | 3,021 | 4,780 |
Letter to EditorComparative real-world clinical assessment of mometasone furoate 0.1% and fluticasone propionate 0.005% in the treatment of atopic dermatitisFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_4_2022 |
3,065 | 1,652 | 4,717 |
Letter to EditorSymmetrical drug-related intertriginous and flexural exanthema without baboon syndrome due to paracetamol: An uncommon side effect of a common drug: A case report and a review of literatureFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_30_2024 |
1,270 | 3,416 | 4,686 |
ObituaryObituary – Professor Marcus Maurer (1966–2024)Full text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_47_2024 |
3,554 | 983 | 4,537 |
